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The examination of rectoanal mucosa-associated lymphoid tissue (RAMALT) biopsy specimens for the
diagnosis of transmissible spongiform encephalopathies has been described in sheep, elk, and small numbers
of mule and white-tailed deer. Previous sample numbers have been too small to validate examination of this
type of tissue as a viable antemortem diagnostic test. In this study, we examined RAMALT collected postmortem from 76 white-tailed deer removed from a farm in Wisconsin known to be affected by chronic wasting
disease (CWD) and from 210 free-ranging white-tailed deer harvested from an area in Wisconsin where the
overall prevalence of CWD among the deer was approximately 4 to 6%. The results of immunohistochemical
(IHC) staining of the RAMALT sections were compared to the results of IHC staining of sections from the
brain stem at the convergence of the dorsal motor nucleus of the vagus nerve, sections of the medial
retropharyngeal lymph nodes (RLNs), and sections of tonsil (sections of tonsil only from captive animals were
tested). The sensitivities of the IHC staining test with RAMALT sections were 81% for the captive animals and
91% for the free-ranging animals. False-negative results were usually associated with early infection, indicated
by a low intensity of immunostaining in the obex and/or a polymorphism at PRNP codon 96. While the RLN
remains the tissue of choice for use for the diagnosis of CWD in white-tailed deer, the results of the present
study further support the use of RAMALTs collected antemortem as an adjunct to testing of tonsil biopsy
specimens and surveillance by necropsy for the screening of farmed deer which have been put at risk through
environmental exposure or exposure to deer with CWD.
Chronic wasting disease (CWD) is a transmissible spongiform encephalopathy that has been reported in free-ranging
and captive Rocky Mountain elk (Cervus elaphus nelsoni), mule
deer (Odocoileus hemionus), white-tailed deer (Odocoileus virginianus), and moose (Alces alces shirasi) in North America (1,
23, 27, 28). Clinical signs of CWD do not appear until very late
in the infection process (11), and as the successful management of CWD appears to be dependent on the early detection
and elimination of infected individuals (8), a reliable diagnostic test for the identification of infected animals during the
early preclinical stage is of paramount importance. Currently,
diagnosis is generally dependent on the finding of PrPCWD, the
abnormal isoform of the cellular prion protein (PrPC), in obex
and/or lymphoid tissues of animals collected postmortem. Antemortem evaluation of tonsil biopsy specimens has been
shown to detect preclinical CWD in deer (17, 26, 29), but the
collection of tonsil tissue is not a universally practical procedure for use in the field, in that it requires general anesthesia
and highly trained personnel to collect adequate samples. On
the basis of the findings of recent studies that have shown that
scrapie-associated PrP (PrPSc) is deposited in the rectoanal

mucosa-associated lymphoid tissues (RAMALTs) of infected
sheep relatively early in the course of infection and that samples from this site can be used to diagnose preclinical scrapie in
sheep (5–7), studies have been conducted with elk and deer to
evaluate the use of RAMALTs for the diagnosis of CWD (11,
21, 24, 30). This study was undertaken to further evaluate the
use of RAMALTs for the diagnosis of CWD in white-tailed
deer from a farm known to be positive for CWD and also in
free-ranging white-tailed deer harvested in an area of Wisconsin known to have a 4 to 6% prevalence of CWD (10) and to
investigate the factors contributing to the false-negative findings with RAMALTs from some deer with CWD.
MATERIALS AND METHODS
Samples from a white-tailed deer farm known to be positive for CWD. Seventy-six white-tailed deer were culled from a deer farm in Portage County, WI,
in January 2006 after detection of the first animal with CWD in September 2002
(11). The animals were euthanized by gunshot, and samples were taken as
follows: brain tissue was frozen for prion protein gene (PRNP) sequence analysis,
and the obex at the level of the convergence of the dorsal motor nuclei of the
vagus nerve (DMNV) where the spinal canal begins was placed in 10% neutral
buffered formalin. Both medial retropharyngeal lymph nodes (RLNs) and both
tonsils were also dissected and placed in formalin. The rectum of each animal
was removed with a scalpel by dissecting a circular area through the skin approximately 1 cm lateral to the anus and cutting progressively deeper while
maintaining traction on the anus (Fig. 1). The rectum was transected 4 to 5 cm
cranial to the anus, and the tissue sample was removed. A longitudinal cut was
made through the anus and rectal lumen with scissors, and the entire tissue was
laid flat, exposing the mucosal surface. The RAMALT is located immediately
beneath the last 1 cm of rectal mucosa proximal to the squamous epithelial tissue
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FIG. 1. Collection of RAMALT from white-tailed deer postmortem. (a) Anus with circular line of demarcation drawn to indicate the line of
incision. (b) The rectum and anus are removed by using a scalpel and dissecting a circular area through the skin approximately 1 cm lateral to the
anus while maintaining traction on the anus. (c) A 4- to 5-cm portion of the rectum and anus is removed. (d) A longitudinal cut has been made
through the anus and rectal lumen, and the entire tissue has been laid flat, thus exposing the mucosal surface. The tip of the scissors indicates the
area in which follicles are found just proximal to the rectoanal junction.

of the rectoanal junction (5–7), and the lymphoid follicles are found in aggregates underneath the crypts of the rectal mucosal folds. The mucosa between the
rectal folds was lifted with fine-tip forceps, and the small “tent” of mucosa was
removed with scissors. This tissue was placed mucosa surface down on a sponge
in the base of a labeled cassette, with care being taken to ensure that all of the
tissue was flattened. A second sponge was placed on top of the tissue to keep it
flat, a lid was fixed to the cassette, and the sample was placed in 10% neutral
buffered formalin. The scalpels, forceps, and scissors were discarded after the
tissue sample was obtained from each animal.
Samples from free-ranging white-tailed deer. Wisconsin Department of Natural Resources biologists collected obex, both RLNs, and RAMALTs from 210
free-ranging white-tailed deer in a manner similar to that described above. The
animals had been culled by agency staff in an area of Wisconsin in which CWD
is known to be enzootic (10).
IHC staining and histology. The obex, RLNs, and RAMALTs were fixed for
a minimum of 5 days before they were processed. The obex was transected at the
level of the convergence of the DMNV, and samples immediately cranial and
caudal were taken with the facing surfaces placed down in a labeled cassette. One
section of RLN and one section of tonsil from captive deer (two samples of
RLNs for free-ranging animals) were placed in a second cassette; and these and
the cassettes containing the RAMALT biopsy specimens were processed, embedded in paraffin, sectioned at 5 m, mounted on positively charged glass slides
(Superfrost/plus; Fisher Scientific, Pittsburgh, PA), deparaffinized, and dehydrated in preparation for immunohistochemistry (IHC) staining, as described
previously (21). Briefly, tissue treatment prior to IHC staining consisted of
immersion of the slide in 98% formic acid solution for 5 min, followed by several
sequential rinses in an acetic acid wash solution buffer and water. Tissue sections
were then autoclaved at 120°C in a proprietary acetic acid solution (Target

Retrieval solution; Dako North America, Inc., Carpinteria, CA) for 20 min with
a 25-min cooling period. The prepared slides were immunolabeled by using an
automated immunostainer (Ventana Medical Systems, Inc., Tucson, AZ) and
anti-PrP murine monoclonal antibody F99/97.6.1, a biotinylated secondary antibody, an alkaline phosphatase-streptavidin conjugate, a substrate chromogen
(fast red A, naphthol, fast red B), and a hematoxylin and bluing counterstain
(Ventana Medical Systems, Inc.) (21, 22). The testing was conducted in accordance with approved practices for the diagnosis of CWD in the United States: a
positive control section was included in each run, and each slide was read by a
pathologist trained in the diagnosis of CWD by IHC staining in a federally
approved veterinary diagnostic laboratory. Tissues were classified as positive if
they contained the typical coarse, bright red, granular immunolabeling in the
DMNV or in the follicles of the RLN, tonsil, or RAMALT (Fig. 2b). No deposits
were detected for samples considered negative (Fig. 2a). An animal was considered positive for CWD if any of the tissues contained positive immunolabeling.
The presence of the DMNV at the level where the spinal canal begins was
required for a section of obex to be acceptable; samples for which this anatomic
region could not be identified were considered unacceptable. The number of
lymphoid follicles per field examined ranged from 0 to ⬎50. A minimum of six
follicles was required to be present in a section of RLN, tonsil, or RAMALT for
the pathologist to designate that section acceptable. For the farmed animals, if
the section was designated unacceptable, another section was taken from the
original block and stained as described above. This was repeated up to four times
for the RAMALT. The tissues from the free-ranging animals were sectioned only
once. Positive sections were scored for IHC staining intensity and distribution, as
described previously (11). Briefly, immunolabeling in the medulla at the level of
the obex where the fourth ventricle enters the spinal canal were scored as
follows: 0, no PrPCWD detected; 1, scant PrPCWD present in ⬍50% of the
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FIG. 2. IHC staining of RAMALT with monoclonal antibody F99/97.6.1. (a) Photomicrograph of several lymphoid follicles in RAMALT of a
white-tailed deer free of PrPCWD; (b) photomicrograph of several lymphoid follicles with heavy immunolabeling of PrPCWD in RAMALT of a
white-tailed deer with chronic wasting disease.

DMNV; 2, PrPCWD present in ⬎50% of the DMNV but no immunolabeling of
the surrounding tissue; 3, DMNV totally filled with PrPCWD with some immunolabeling of surrounding tissue; and 4, heavy PrPCWD deposits within the
DMNV and the surrounding tissue. Lymphoid tissue (RLN, tonsil, and
RAMALT) was considered to have a score of 0 if no PrPCWD was detected in
lymphoid follicles, a score of 1 if less than six PrPCWD-positive follicles were
detected in the entire section examined, a score of 2 if more than six positive
follicles were detected in a field examined in a section in which some fields had
no stain in any follicles, and a score of 3 if PrPCWD was detected in follicles in all
fields examined.
Prion protein genotyping. The allelic sequence of the prion protein gene
(PRNP) was determined for the farmed animals by PCR and DNA sequence
analysis (15). Genotypes with the sequence encoding glutamine (Q) at codon 95,
glycine (G) at codon 96, alanine at codon 116, and glutamine at codon 226 were
considered to be homozygous for the wild-type (wt) allele and are indicated
wt/wt. Alleles with polymorphisms at codon 96, G to serine (G96S), and codon
226, Q to lysine (Q226K), were observed; and deer heterozygous for these alleles
and the wt allele are designated wt/G96S and wt/Q226K, respectively. Homozygous G96S (G96S/G96S) deer were rare in the population, and homozygous
Q226K/Q226K deer were not observed. Genotyping was not performed on all the
samples from free-ranging deer; state and federally supported surveillance programs test large numbers of animals during the annual U.S. and Canadian
hunting season, and genotype analysis of those samples is not cost-effective.
Data analysis. Deer were considered CWD positive if PrPCWD was detected in
any of the tissue samples examined (obex, tonsils from captive animals, or
RLNs). The tissue-specific sensitivity for PrPCWD detection by IHC staining was
expressed as the percentage with positive detection compared to the total number evaluated from CWD-positive deer. The statistical and graphing software
used were JMP for Windows (version 8.0; SAS Institute Inc., Cary, NC) and
Origin (version 6.0; Microcal Software Inc., Northampton, MA), respectively.

RESULTS
Detection of PrPCWD in RAMALTs compared with that in
RLNs and tonsils. CWD surveillance in deer is currently based
on examination of the RLN, the tissue in which PrPCWD is
most likely to be detected in infected animals. Tonsil biopsy
specimens from live animals are used because the tissue is
accessible to trained personnel. The frequency of detection of
PrPCWD in the RAMALTs of CWD-positive captive deer was
related to the PrPCWD scores in RLNs (Fig. 3a, upper panels)
and tonsils (Fig. 3b, upper panels).
PRNP genotype and RAMALT test sensitivity. The PRNP
genotype is related to the prevalence of CWD in free-ranging
deer (9, 11, 15) and the sensitivity of tests with RAMALTs
from experimentally infected white-tailed deer (30). We there-

fore evaluated the effect of genotype on the results obtained
with RAMALTs for the CWD-positive captive deer in this
study (Fig. 3a and b, lower panel). Note that PrPCWD was
detected in the RAMALTs of 41 of 43 (95%) CWD-positive
wt/wt deer in which PrPCWD was also detected in the RLNs
and/or tonsils (Table 1). In CWD-positive wt/G96S deer, however, PrPCWD was detected in the RAMALTs of only 7 of 14
(50%) deer in which PrPCWD was also detected in the RLNs
and/or tonsils and was detected only in the RAMALTs of deer
in which the RLN and/or tonsil PrPCWD scores were 3. In this
study, the odds for the detection of PrPCWD in the RAMALTs
in wt/G96S deer with CWD was 0.073 times lower than that in
wt/wt deer with CWD (95% confidence interval, 0.015 to 0.352;
two-tailed Fisher’s exact test, P ⫽ 0.0009).
Infection stage and sensitivity of test with RAMALTs. To
define the potential sources of the false-negative findings with
RAMALTs, the infection status of each animal was estimated
from the obex score. As shown in the upper panel of Fig. 3c,
the frequency of detection of PrPCWD in the RAMALTs of
CWD-positive captive deer was related to the obex PrPCWD
score. This relationship is subcategorized by the codon 96
genotype (Fig. 3c, lower panel) because G96S has been significantly associated with disease progression (11, 30). Note that
during early infection (obex scores, 0 and 1), PrPCWD was
detected in the RAMALTs from only 1 of 8 (13%) wt/G96S
deer, whereas PrPCWD was detected in 10 of 12 (83%) wt/wt
deer. PrPCWD was detected in the RAMALTs of 100% of the
wt/wt and wt/G96S deer in this study that were further progressed in disease (obex scores, 2 to 4).
For the 11 CWD-positive captive deer in which no PrPCWD
was detected within the RAMALTs (potential false-negative
results), the PrPCWD scores for the RLNs and tonsils were 0 or
1 (absent or minimal) in five deer (including one deer in which
PrPCWD was detected only in the obex) and 2 or 3 (moderate
or strong) in at least one of these tissues in six deer. Ten of the
11 RAMALT-negative deer had an obex score of less than 2;
the obex sample from one deer was considered unacceptable
for scoring. The 11 RAMALT-negative CWD-positive captive
deer included two fawns, four yearlings, four deer that were 2
years of age, and a 3-year-old animal.
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FIG. 3. Relationship of PrPCWD detection in the RAMALT with PrPCWD IHC staining scores for the medial RLN, tonsil, and obex from a
captive herd of CWD-positive white-tailed deer. Bars depict the probability of PrPCWD detection (probability POS) in the RAMALTs for all
CWD-positive deer (upper panels) or by PrP genotype at codon 96 (lower panels; GG ⫽ wt/wt, GS ⫽ wt/G96S). The number above each bar
indicates the number of deer; *, inclusion of one homozygous G96S deer.

Of the 210 free-ranging white-tailed deer sampled, PrPCWD
was detected in the RAMALTs of 10 of 11 (91%) CWDpositive deer; the RAMALT samples from two additional
CWD-positive deer were unacceptable for evaluation. All 10 of
the RAMALT-positive free-ranging deer had a PrPCWD RLN
score of 3 and 3 had obex scores of less than 2. The single
RAMALT-negative, CWD-positive deer had an RLN score of
1 and an obex score of 0.
Acceptability of samples from captive and wild populations.
Four sections of obex (5.3%) and three sections of RAMALT
(3.9%) from the farmed deer were considered unacceptable
for diagnostic evaluation. Seven sections of obex (3.3%) and 44
sections of RAMALT (21%) from the 210 free-ranging whitetailed deer were considered unacceptable.

the accumulation of PrPCWD occurs in the RLNs or tonsils
prior to accumulation in the obex (11) and the presence of
PrPCWD in the RLNs and tonsils is a reliable marker for the
antemortem and preclinical postmortem diagnosis of CWD
(26, 29, 30). The collection of lymphatic tissues from the head
and neck of live animals is not an easy task; tonsil biopsy
procedures require general anesthesia, the tonsil is difficult to
visualize, the collection of a tonsil biopsy specimen requires
experienced personnel, and the samples tend to be small (4 or
6 mm). As a tool for the screening of free-ranging or captive
populations, this technique is not as efficient or as economical
as rectal tissue biopsy. The latter procedure can be performed
without general anesthesia, visualization of the rectal mucosa
is much easier than that of the tonsil, and larger samples can be
obtained without the need for specialized equipment. However, the diagnosis of CWD by the use of RAMALTs, as with
tonsil tissues, is dependent on the collection of adequate
samples.
An adequate lymphoid tissue sample in our study was defined as one with at least six follicles in any one section exam-

DISCUSSION
On the basis of the results of our study, the detection of
PrPCWD in RAMALTs by IHC staining should be considered
a useful tool for the preclinical diagnosis of CWD in whitetailed deer. It was previously shown that in white-tailed deer,

TABLE 1. Number of animals of different genotypes positive for PrPCWD in obex, medial RLN, tonsil, and RAMALT
Genotype

wt/wt
wt/G96S
G96S/G96S
wt/Q226K
G96S/Q226K
a
b
c

Total no. of
animals

51
21
2
1
1

Two samples were not suitable for evaluation.
One sample was not suitable for evaluation.
Samples were not suitable for evaluation.

No. (%) of animals positive by evaluation of the following:
Total

44 (86.3)
14 (66.7)
1 (50)
1 (100)
0

Obex
a

42 (95.5)
7b (50)
0
0c
0

RLNs

Tonsils

RAMALTs

43 (97.7)
13 (92.9)
1 (50)
1 (100)
0

43 (97.7)
12 (85.7)
0
1 (100)
0

41 (93.2)
7 (50)
0
0c
0
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ined. A recent study (21) demonstrated that similar testing of
elk required 10 follicles, and higher rates of false-negative
results for sheep were observed when the samples had less than
14 follicles (7). Previous studies with tonsil biopsy specimens
have defined adequate sections as having just one follicle (29)
or less than three follicles (26) per section, so a direct comparison of the number of adequate samples between rectal and
tonsil biopsy specimens is difficult. We were unable to obtain
adequate RAMALT samples from 3 of the captive animals
(3.9%) and 44 (21%) of the free-ranging animals, even though
the samples were collected postmortem. Some of this difference may be explained by the collection technique used; the
samples from the captive animals were collected by one experienced veterinarian, and the samples from the free-ranging
animals were collected by a number of wildlife biologists with
limited training. However, the major difference is likely explained by the number of sections of RAMALT examined for
individuals in each population. The RAMALT samples in this
study were embedded with the mucosal surface down, which
requires the use of a precise sectioning technique to ensure
that the sections are not taken too shallow, in which case there
will be few lymphoid follicles and large numbers of crypts, or
too deep, in which case a large percentage of lymphoid follicles
will have been lost and submucosal tissue and muscle will be
present. In the farmed deer, several sections from various
depths of the mucosa were examined in an attempt to have at
least six follicles present in a single section. This procedure was
not done for animals in the wild population, in which only one
section from each animal was examined, which more closely
approximates the procedure that would be used for high-volume sampling schemes. The number of unsuitable samples
from the free-ranging population could likely have been decreased considerably by collecting sections from various depths
of the block. This is an important aspect to keep in mind when
laboratory personnel are being trained.
In this study, the sensitivity of IHC staining of RAMALTs
was approximately 80%, which is slightly lower than the estimated sensitivity of the testing of RAMALTs for the diagnosis
of scrapie in sheep (5–7). As with sheep, the sensitivity of the
test is apparently improved by the exclusion of animals with
genotypes associated with reduced PrPSc or PrPCWD accumulation, very young animals, or animals with very early disease.
In white-tailed deer, the wt/G96S genotype is associated with a
delay in the progression of CWD infection (11, 30), and the
confounding effects of a prolonged early infection stage and
the PRNP genotype itself cannot be resolved for this sample
set. The mechanism by which the PRNP genotype influences
the kinetics of PrPCWD deposition in the tissues of white-tailed
deer (9, 11, 15, 30) is not known. In the current study, 41/44
(93%) of the CWD-positive wt/wt deer were RAMALT positive but only 7/14 (50%) of the CWD-positive wt/G96S deer
were RAMALT positive. This finding is consistent with that of
an experimental pathogenesis trial (30) in which 90% (9/10) of
the experimentally infected PRNP wt/wt deer were RAMALT
positive at 342 days postinfection, although only 50% (4/8) of
the wt/G96S deer were RAMALT positive at 381 days postinfection. The use of RAMALTs for the testing of captive herds
may benefit from supplementary PRNP genotype testing to
identify deer likely to have false-negative RAMALT findings.
The G96S homozygous population and Q226K homozygous or
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heterozygous deer were relatively rare in the populations examined; and there were insufficient numbers of animals of the
G96S/G96S, wt/Q226K, and G96S/Q226K genotypes in our
study to determine the role of those PRNP genotypes in the
testing of RAMALTs.
With the exception of one fawn in the current study, there
was no evidence of a nonlymphocytic scrapie strain responsible for CWD comparable to the ovine Nor98 scrapie strain
(2) or of a lymphoid-sparing deposition pattern, as has been
observed in some studies of classical sheep scrapie (13, 16,
25) and in up to 15% of elk with CWD (20). However, the
deer in this study represented only a single captive population and a sample of free-ranging animals originating from
a relatively small geographic area. The findings of this study
may therefore be limited to a single strain of CWD. The
presence of multiple strains responsible for CWD is suggested by studies with a transgenic mouse model (3). Although additional strains responsible for CWD may be discovered as our understanding of prion strains (4) and strain
typing methodologies are refined and developed, this and
previous studies (9, 11, 12, 15) suggest that the predominant
U.S. strains result in the early deposition of PrPCWD in
lymphoid tissue in most white-tailed deer.
This study was performed by using an IHC detection method
validated for use in approved veterinary diagnostic laboratories in the United States. Adaptation and validation of laboratory methods such as protein misfolding cyclic amplification
assay (19) or paraffin-embedded tissue immunoblotting (18)
may increase the sensitivity of diagnostic testing of RAMALTs
from deer. Those methods may also be useful adjuncts to
bioassay methods (14) for estimation of the potential of fecal
shedding of prions from the gut of deer with PrPCWD-positive
tissues in the gastrointestinal tract.
The results of this study are remarkably similar to those
reported from a similar study describing the IHC detection of
PrPSc in the RAMALTs of sheep with classical scrapie (6). The
sensitivity of the assay in that study was 86% with sheep with
preclinical CWD. False-negative readings were observed for
young sheep, many with scant accumulations of PrPSc in other
lymphoid tissues and older sheep with genotypes associated
with prolonged incubation times and scant lymphoid accumulation of PrPSc at all stages of infection.
The RLN is the most sensitive indicator of CWD but is
suitable for use only for analysis by necropsy. Because the
sensitivity of the PrPCWD IHC assay with RAMALTs does not
appear to be as high as it is with tonsil tissues, the use of
RAMALT biopsy specimens may not be as reliable a tool as
the use of tonsil biopsy specimens for the testing of individual
animals for the purpose of movement. However, the advantages of cost and ease of sampling make testing of RAMALTs
a reasonable alternative in situations in which large numbers of
live white-tailed deer are to be tested. This study further supports the use of RAMALTs as an alternative or adjunct to
tonsil biopsy specimens, particularly for farmed deer with
potential environmental exposure or exposure to cervids
with CWD.
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